Furthermore, organic cation transporter 2 (OCTN2), a cation/carnitine transporter, is crucial in COPD drug therapy, affecting the distribution and absorption of COPD medications in the lungs. Here, SLC22A2 is linked to chronic obstructive pulmonary disease.